- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04219384
Hjärtstopp relaterat till kritisk sjukdom (CIRCA) (CIRCA)
Critical Illness Related Cardiac Arrest (CIRCA): en undersökning av förekomsten och resultatet av hjärtstopp inom intensivvårdsavdelningar i Storbritannien
CIRCA aims to determine the incidence and outcomes of in-hospital cardiac arrest (IHCA) in UK intensive care units (ICUs) and explore associated risk factors with ICU and hospital survival and quality of survival following hospital discharge.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Cardiac arrest is often categorised by location, out-of-hospital or in-hospital (IHCA), as there are important differences in population characteristics and aetiology. The National Cardiac Arrest Audit (NCAA) was established to audit resuscitation teams in response to IHCA, and collects information about patient characteristics, resuscitation processes, and patient outcomes. However, it does not audit IHCAs that are not attended by the resuscitation team.
Critically ill patients managed in ICUs are experiencing failure of one or more organs and therefore more intensive and invasive therapies are needed to support these failing organs. As a result, ICUs have higher nursing and medical staffing ratios, and monitoring is usually continuous. Moreover, the skill mix of the multidisciplinary team is geared to advanced life support. Thus, the risk of cardiac arrest occurring, the involvement (or not) of the resuscitation team, and the probability of return of spontaneous circulation are all likely to be different to other IHCAs.
Accurate data on cardiac arrests in ICU are lacking and the investigators do not know how many IHCA occur in ICU in the UK, nor is the impact of an IHCA in ICU on outcome known. In addition, it is not known if these IHCAs in ICUs represent an unavoidable consequence of critical illness or, more importantly, whether they can be predicted and/or prevented.
CIRCA is a prospective, multi-centre observational cohort study nested in the Case Mix Programme (CMP) and NCAA national clinical audits. The investigators aim to determine the incidence and outcomes of IHCA in UK ICUs and explore associated risk factors with ICU and hospital survival and quality of survival following hospital discharge.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
London, Storbritannien, WC1V 6AZ
- Intensive Care National Audit & Research Centre
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Adults having cardiac arrest (defined as receipt of chest compressions and/or defibrillation) after admission to an Intensive Care Unit (ICU) participating in the Case Mix Programme in a hospital participating in the National Cardiac Arrest Audit
Beskrivning
Inclusion Criteria:
- Age 18 years old or more; and either
- Cardiac arrest (defined as receipt of chest compressions or defibrillation) occurring while in-hospital and within intensive care (defined as either ICU, HDU or combined ICU/HDU); or
- Family member of a patient surviving to discharge from intensive care after a cardiac arrest within ICU
Exclusion Criteria:
There are no exclusion criteria
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Critical-illness related cardiac arrest (CIRCA)
Those experiencing a critical illness-related cardiac arrest in a participating adult, general ICU |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence
Tidsram: Up to 12 months
|
Incidence of critical illness related cardiac arrest |
Up to 12 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Subsequent incidence of in-hospital cardiac arrest
Tidsram: Up to 12 months
|
Subsequent incidence of in-hospital cardiac arrest obtained through data linkage to the National Cardiac Arrest Audit |
Up to 12 months
|
|
Survival status at hospital discharge
Tidsram: Up to 12 months
|
Survival status at hospital discharge obtained from data linkage to the Case Mix Programme |
Up to 12 months
|
|
Survival status at 12 months
Tidsram: 12 months
|
Survival status at 12 months obtained from data linkage to NHS Digital |
12 months
|
|
Patient quality of life measured through EQ-5D-5L questionnaire completion at 3 months
Tidsram: 3 months
|
Patient quality of life measured through completion of EuroQol 5 Dimension (5 level) questionnaire at 3 months following critical illness related cardiac arrest |
3 months
|
|
Patient quality of life measured through EQ-5D-5L questionnaire completion at 6 months
Tidsram: 6 months
|
Patient quality of life measured through completion of EuroQol 5 Dimension (5 level) questionnaire at 6 months following critical illness related cardiac arrest |
6 months
|
|
Patient quality of life measured through EQ-5D-5L questionnaire completion at 12 months
Tidsram: 12 months
|
Patient quality of life measured through completion of EuroQol 5 Dimension (5 level) questionnaire at 12 months following critical illness related cardiac arrest |
12 months
|
|
Patient quality of life measured through IQCODE questionnaire completion at 3 months
Tidsram: 3 months
|
Patient quality of life measured through completion of Informant Questionnaire on Cognitive Decline in the Elderly questionnaire at 3 months following critical illness related cardiac arrest |
3 months
|
|
Patient quality of life measured through IQCODE questionnaire completion at 6 months
Tidsram: 6 months
|
Patient quality of life measured through completion of Informant Questionnaire on Cognitive Decline in the Elderly questionnaire at 6 months following critical illness related cardiac arrest |
6 months
|
|
Patient quality of life measured through IQCODE questionnaire completion at 12 months
Tidsram: 12 months
|
Patient quality of life measured through completion of Informant Questionnaire on Cognitive Decline in the Elderly questionnaire at 12 months following critical illness related cardiac arrest |
12 months
|
|
Family member quality of life measured through FROM-16 questionnaire completion at 3 months
Tidsram: 3 months
|
Quality of life of family member of patients surviving critical illness related cardiac arrest measured through completion of Family Reported Outcome Measures 16 questionnaire at 3 months following patient arrest |
3 months
|
|
Family member quality of life measured through FROM-16 questionnaire completion at 6 months
Tidsram: 6 months
|
Quality of life of family member of patients surviving critical illness related cardiac arrest measured through completion of Family Reported Outcome Measures 16 questionnaire at 6 months following patient arrest |
6 months
|
|
Family member quality of life measured through FROM-16 questionnaire completion at 12 months
Tidsram: 12 months
|
Quality of life of family member of patients surviving critical illness related cardiac arrest measured through completion of Family Reported Outcome Measures 16 questionnaire at 12 months following patient arrest |
12 months
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Matt Thomas, MD, North Bristol NHS Trust
Publikationer och användbara länkar
Allmänna publikationer
- Darnell R, Broomhall J, Newell C, Gendall E, Harrison D, Rowan K, Doidge J, Mouncey P, Gould D, Thomas M. Critical Illness Related Cardiac Arrest (CIRCA): a prospective investigation of the incidence and outcome of cardiac arrest within intensive care units in the United Kingdom. Resuscitation. 2026 Feb;219:110933. doi: 10.1016/j.resuscitation.2025.110933. Epub 2025 Dec 22.
- Darnell R, Newell C, Edwards J, Gendall E, Harrison D, Sprinckmoller S, Mouncey P, Gould D, Thomas M. Critical illness-related cardiac arrest: Protocol for an investigation of the incidence and outcome of cardiac arrest within intensive care units in the United Kingdom. J Intensive Care Soc. 2022 Nov;23(4):493-497. doi: 10.1177/17511437211055899. Epub 2022 Mar 13.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ICNARC/02/11/2019
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
An anonymised study dataset will be available from ICNARC on request to the Chief Investigator, subject to any necessary approvals
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .